Chill Brands Group PLC

PINK:CHBRF USA Drug Manufacturers - Specialty & Generic
Market Cap
$16.45 Million
Market Cap Rank
#30012 Global
#9913 in USA
Share Price
$0.03
Change (1 day)
+0.00%
52-Week Range
$0.03 - $0.03
All Time High
$1.45
About

Chill Brands Group PLC engages in the research and development, production, and sale of cannabidiol consumer products and other lifestyle goods in the United States, the United Kingdom, and rest of Europe. It offers tobacco alternative products, including CBD-infused oral chew pouches and herbal smokes. The company also provides CBD-infused topical creams, beauty products, and ingestible tincture… Read more

Chill Brands Group PLC (CHBRF) - Net Assets

Latest net assets as of September 2023: $-699.73K USD

Based on the latest financial reports, Chill Brands Group PLC (CHBRF) has net assets worth $-699.73K USD as of September 2023.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($4.45 Million) and total liabilities ($5.15 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $-699.73K
% of Total Assets -15.72%
Annual Growth Rate -6.38%
5-Year Change -86.09%
10-Year Change N/A
Growth Volatility 171.91

Chill Brands Group PLC - Net Assets Trend (2016–2023)

This chart illustrates how Chill Brands Group PLC's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Chill Brands Group PLC (2016–2023)

The table below shows the annual net assets of Chill Brands Group PLC from 2016 to 2023.

Year Net Assets Change
2023-03-31 $878.67K -42.94%
2022-03-31 $1.54 Million +786.96%
2021-03-31 $-224.18K -110.62%
2020-03-31 $2.11 Million -66.58%
2019-03-31 $6.32 Million -32.56%
2018-03-31 $9.37 Million +33.66%
2017-03-31 $7.01 Million +402.80%
2016-03-31 $1.39 Million --

Equity Component Analysis

This analysis shows how different components contribute to Chill Brands Group PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 1709922300.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (March 2023)

Component Amount Percentage
Common Stock $2.61 Million 297.17%
Other Comprehensive Income $6.25 Million 711.48%
Other Components $10.92 Million 1243.13%
Total Equity $878.67K 100.00%

Chill Brands Group PLC Competitors by Market Cap

The table below lists competitors of Chill Brands Group PLC ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Chill Brands Group PLC's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2022 to 2023, total equity changed from 1,540,038 to 878,672, a change of -661,366 (-42.9%).
  • Net loss of 4,287,891 reduced equity.
  • New share issuances of 2,004,013 increased equity.
  • Other comprehensive income increased equity by 2,511,512.
  • Other factors decreased equity by 889,000.

Equity Change Factors (2022 to 2023)

Factor Impact Contribution
Net Income $-4.29 Million -488.0%
Share Issuances $2.00 Million +228.07%
Other Comprehensive Income $2.51 Million +285.83%
Other Changes $-889.00K -101.18%
Total Change $- -42.94%

Book Value vs Market Value Analysis

This analysis compares Chill Brands Group PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 8.99x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 0.39x to 8.99x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2016-03-31 $0.08 $0.03 x
2017-03-31 $0.14 $0.03 x
2018-03-31 $0.10 $0.03 x
2019-03-31 $0.05 $0.03 x
2020-03-31 $0.01 $0.03 x
2021-03-31 $0.00 $0.03 x
2022-03-31 $0.01 $0.03 x
2023-03-31 $0.00 $0.03 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Chill Brands Group PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -488.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -5176.11%
  • • Asset Turnover: 0.01x
  • • Equity Multiplier: 6.99x
  • Recent ROE (-488.00%) is below the historical average (-188.29%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 -130.33% 0.00% 0.00x 1.04x $-1.96 Million
2017 -48.07% 0.00% 0.00x 1.05x $-4.07 Million
2018 -42.45% -137.07% 0.24x 1.29x $-4.91 Million
2019 -91.35% -567.76% 0.13x 1.21x $-6.40 Million
2020 -335.25% -7643.69% 0.03x 1.58x $-7.29 Million
2021 0.00% -1853.31% 0.18x 0.00x $-5.92 Million
2022 -370.87% -915.03% 0.19x 2.12x $-5.87 Million
2023 -488.00% -5176.11% 0.01x 6.99x $-4.38 Million

Industry Comparison

This section compares Chill Brands Group PLC's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $580,491,146
  • Average return on equity (ROE) among peers: -45.37%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Chill Brands Group PLC (CHBRF) $-699.73K -130.33% N/A $7.00 Million
Ascend Wellness Holdings Inc (AAWH) $142.87 Million -33.75% 5.44x $48.90 Million
AB Science S.A (ABSCF) $14.78 Million -64.19% 0.99x $39.89 Million
Alterola Biotech Inc (ABTI) $-241.47K 0.00% 0.00x $603.58K
Aurora Cannabis Inc (ACB) $521.74 Million -329.21% 0.78x $194.64 Million
Acreage Holdings Inc (ACRDF) $494.79 Million -30.37% 0.40x $13.48K
Acura Pharmaceuticals Inc (ACUR) $37.06 Million 39.05% 0.16x $13.20K
Agra Ventures Ltd. (AGFAF) $1.51 Million -44.22% 0.06x $298.23K
Allergy Therapeutics plc (AGYTF) $32.70 Million -18.88% 0.16x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $21.19 Million 12.93% 1.96x $1.84
Adcock Ingram Holdings Limited (AIHLF) $4.54 Billion 14.90% 0.58x $85.61 Million